Literature DB >> 7641949

The early treatment of posterior crossbites: a review of continuing controversies.

S Ninou1, C Stephens.   

Abstract

A posterior crossbite may pose long-term risk through causing associated displacement in the mandibular path of closure. In this paper the authors review the current opinions on treatment of such a problem.

Mesh：

Year:  1994        PMID： 7641949

Source DB:  PubMed          Journal:  Dent Update        ISSN： 0305-5000


  6 in total

1.  Fixed Appliance with Expansion Screw for the Treatment of Primary Anterior Crossbite.

Authors:  Sanchit Paul; Ashwin Rao; Paul Chalakkal; Saranya Mony
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Mandibular asymmetry in unilateral and bilateral posterior crossbite patients using cone-beam computed tomography.

Authors:  Ilknur Veli; Tancan Uysal; Torun Ozer; Faruk Izzet Ucar; Murat Eruz
Journal:  Angle Orthod       Date:  2011-05-18       Impact factor: 2.079

Review 3.  Orthodontic treatment for posterior crossbites.

Authors:  Alessandro Ugolini; Paola Agostino; Armando Silvestrini-Biavati; Jayne E Harrison; Klaus Bsl Batista
Journal:  Cochrane Database Syst Rev       Date:  2021-12-24

Review 4.  The effectiveness of the early orthodontic correction of functional unilateral posterior crossbite in the mixed dentition period: a systematic review and meta-analysis.

Authors:  Danya Hassan Alsawaf; Salam Ghazwan Almaasarani; Mohammad Y Hajeer; Nada Rajeh
Journal:  Prog Orthod       Date:  2022-02-14       Impact factor: 3.247

5.  Hexa helix: modified quad helix appliance to correct anterior and posterior crossbites in mixed dentition.

Authors:  Syed Mohammed Yaseen; Ravindranath Acharya
Journal:  Case Rep Dent       Date:  2012-10-16

6.  Three-dimensional evaluation of facial asymmetry in association with unilateral functional crossbite in the primary, early, and late mixed dentition phases.

Authors:  Jasmina Primozic; Giuseppe Perinetti; Stephen Richmond; Maja Ovsenik
Journal:  Angle Orthod       Date:  2012-08-13       Impact factor: 2.079
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.